Security key
68572M106
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO)
CUSIP: 68572M106
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 23,094,571
- Total 13F value
- $98,187,766
- Share change
- +559,490
- Put/Call ratio
- 0%
- SEC-reported price per share
- $4.25
- Number of holders
- 65
- Value change
- +$2,482,033
- Number of buys
- 39
- Number of sells
- 29
- Shares outstanding
- 62,199,969
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
65
Top holders
10
OBIO full security history
Ownership snapshot
Full 13F holder table
Orchestra BioMed Holdings, Inc. SEC filings
Orchestra BioMed Holdings, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OBIO - Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Medtronic plc
Disclosed value leader
Medtronic plc
Comparable rows
15/15
Latest evidence
31 Dec 2025
3/4/5
13D/G
13F
Lead comparable stake: 18%
13D/G row: Medtronic plc
Showing 1-6 of 15 holder rows.
Quick read
Medtronic plc leads the comparable SEC ownership view at 18%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Medtronic plc's linked filing trail.
Comparable ownership
Top 5
Medtronic plc
18%
PERCEPTIVE ADVISORS LLC
10%
Tasso Partners, LLC
5.5%
BlackRock, Inc.
3.7%
RTW INVESTMENTS, LP
13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medtronic plc |
3/4/5
13D/G
10%+ Owner
|
18%
from 13D/G
|
$94,137,413
5,868,916 shares
|
— | 31 Dec 2023 |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
3/4/5
Company · 10%+ Owner
|
10%
from 13D/G
|
$21,278,112
5,127,256 shares
|
— | 31 Dec 2025 |
| Tasso Partners, LLC |
13D/G
Dana Lorenzo
|
5.5%
|
$7,684,508
3,098,592 shares
|
$0 | 15 Nov 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
3.7%
|
$3,619,674
1,430,701 shares
|
$0 | 31 Mar 2025 |
| RTW INVESTMENTS, LP |
13F
Company
|
13%
|
$34,470,161
8,306,063 shares
|
— | 31 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2.6%
|
$6,658,907
1,604,556 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
65
Shares
23,094,571
Rows available
65
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
65
Q1 2026 holders
65
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|